Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study

Inflammatory Bowel Diseases

Volumn 13, Issue 12, 2007, Pages 1493-1501

  Yamamoto, Takayuki ^a   Nakahigashi, Maki ^a   Saniabadi, Abbi R ^b   Iwata, Takashi ^a   Maruyama, Yasuki ^a   Umegae, Satoru ^a   Matsumoto, Koichi ^a  

^a MIE UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY   (Japan)

Author keywords

Crohn's disease; Cytokine; Elemental diet; Endoscopic inflammation; Enteral nutrition; Mucosa; Relapse

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERIC FEEDING; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFLAMMATION; INTESTINE MUCOSA; LOW FAT DIET; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCORING SYSTEM; TISSUE LEVEL;

ADULT; BIOPSY; CROHN DISEASE; CYTOKINES; DIET, FAT-RESTRICTED; ENDOSCOPY, GASTROINTESTINAL; ENTERAL NUTRITION; FEMALE; FOOD, FORMULATED; HUMANS; INTESTINAL MUCOSA; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 38049014903     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20238     Document Type: Article

References (37)

1. Zurita VF, Rawls DE, Dyck WP. Nutritional support in inflammatory bowel disease. Dig Dis. 1995;13:92-107.
2. King TS, Woolner JT, Hunter JO. Review article: the dietary management of Crohn's disease. Aliment Pharmacol Ther. 1997;11:17-31.
3. Hiwatashi N. Enteral nutrition for Crohn's disease in Japan. Dis Colon Rectum. 1997;40(Suppl 10):S48-53.
4. Matsui T, Sakurai T, Yao T. Nutritional therapy for Crohn's disease in Japan. J Gastroenterol. 2005;40(Suppl 16):25-31.
5. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr. 2006;25:260-274.
6. Fukuda Y, Kosaka T, Okui M, et al. Efficacy of nutritional therapy for active Crohn's disease. J Gastroenterol. 1995;30(Suppl 8):83-87.
7. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ. 1984;288:1859-1862.
8. Saverymuttu S, Hodgson HJ, Chadwick VS. Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut. 1985;26:994-998.
9. Verma S, Kirkwood B, Brown S, et al. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis. 2000;32:769-774.
10. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an "half elemental diet" as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333-1340.
11. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25:67-72.
12. Winitz M, Adams RF, Seedman DA, et al. Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations. Am J Clin Nutr. 1970;23:546-559.
13. Crowther JS, Drasar BS, Goddard P, et al. The effect of a chemically defined diet on the faecal flora and faecal steroid concentration. Gut. 1973;14:790-793.
14. Teahon K, Smethurst P, Pearson M, et al. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology. 1991;101:84-89.
15. Teahon K, Pearson M, Smith T, et al. Alterations in nutritional status and disease activity during treatment of Crohn's disease with elemental diet. Scand J Gastroenterol. 1995;30:54-60.
16. Meister D, Bode J, Shand A, et al. Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro. Dig Liver Dis. 2002;34:430-438.
17. Ligumsky M, Simon PL, Karmeli F, et al. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut. 1990;31:686-689.
18. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut. 1989;30:835-838.
19. Pullman WE, Elsbury S, Kobayashi M, et al. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology. 1992;102:529-537.
20. Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-α, interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut. 1996;39:684-689.
21. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis. 2005;11:580-588.
22. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000;14:281-289.
23. Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther. 1995;9:547-552.
24. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
25. Wardle TD, Hall L, Turnberg LA. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut. 1992;33:1644-1651.
26. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995;108:1056-1067.
27. Fernández-Bañares F, Cabré E, Esteve-Comas M, et al. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356-364.
28. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8-15.
29. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut. 1993;34:1198-1202.
30. Malchow H, Steinhardt HJ, Lorenz-Meyer H, et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol. 1990;25:235-244.
31. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology. 1991;101:881-888.
32. Lindor KD, Fleming CR, Burnes JU, et al. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc. 1992;67:328-333.
33. Yamamoto T, Umegae S, Kitagawa T, et al. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse. Aliment Pharmacol Ther. 2004;19:671-678.
34. Yamamoto T, Umegae S, Kitagawa T, et al. Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective, pilot study. Inflamm Bowel Dis. 2005;11:589-596.
35. Yamamoto T, Umegae S, Kitagawa T, et al. The impact of the fecal stream and stasis on immunologic reactions in ileal pouch after restorative proctocolectomy for ulcerative colitis: a prospective, pilot study. Am J Gastroenterol. 2005;100:2248-2253.
36. Fernández-Bañares F, Cabré E, González-Huix F, et al. Enteral nutrition as primary therapy in Crohn's disease. Gut. 1994;35(Suppl 1):S55-59.
37. Lewis JD, Fisher RL. Nutrition support in inflammatory bowel disease. Med Clin North Am. 1994;78:1443-1456.